Antibiotics: Merck Manual Home Edition Antibiotics Type Drug Common Uses Side Effects Aminoglycosides - Amikacin Gentamicin Kanamycin Neomycin Netilmicin Streptomycin Tobramycin Infections caused by gram-negative bacteria, such as Escherichia coli and Klebsiella Hearing loss Dizziness Kidney damage Carbecephem - Loracarbef - - Carbapenems - Ertapenem Imipenem/ cilastatin Meropenem Gangrene, sepsis, pneumonia, abdominal...
Medicis.com | The Dermatology Company -About Medicis Business Development Careers Investor Relations Products R&D Governance Site Map - Medicis, The Dermatology Company ® Dynacin ® (minocycline HCl) The number one branded minocycline among dermatologists.
Index: CE: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Antibiotics: Merck Manual Home Edition Antibiotics Type Drug Common Uses Side Effects Aminoglycosides - Amikacin Gentamicin Kanamycin Neomycin Netilmicin Streptomycin Tobramycin Infections caused by gram-negative bacteria, such as Escherichia coli and Klebsiella Hearing loss Dizziness Kidney damage Carbecephem - Loracarbef - - Carbapenems - Ertapenem Imipenem/ cilastatin Meropenem Gangrene, sepsis, pneumonia, abdominal...
Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Amoxicillin, amoxicillin with clavulanate, amoxicillin with clavulanate potassium,...
Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Amoxicillin, amoxicillin with clavulanate, amoxicillin with clavulanate potassium,...
http://www.biosis.org/ts/media/cdjournals/gazettenews/2003/CPG_News_0325.pdf Drug Patenting in Context ISSN:1464-3499 week 0325 20 June 2003 Ortho-McNeil have disclosed a new alkynyl target structure for their long running antihistamine projects...
http://www.biosis.org/ts/media/cdjournals/gazettenews/2003/CPG_News_0343.pdf week 0343 24 Oct 2003 AstraZeneca has claims to a range of histone deacetylase (HDAC) inhibitors, possibly a new target for the company Drug Patenting in Context A five-year period of extended protection under SPC/GB97/091 began on September 23 rd 2003 for Fujisawa’s cefdinir. cefdinir case is technically related to an earlier one covering cefixime, EP29557,...
Gazette Highlights News 2003 - Thomson Scientific Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Gazette Weekly Highlights News : Gazette Highlights News 2003 - Gazette Highlights News 2003 Click on a week to view more Week 51: This issue of Current Patents Gazette is the final one for 2003...
Drug Approvals - O ANDA 75-347 3/23/00 3/31/00 - - Omnicef (cefdinir) Capsules,- Abbott Laboratories NDA 50-739/S-006 7/24/02 8/6/02 Omnicef (cefdinir) Capsules,- Parke-Davis NDA 50-739/S-002 11/24/99 12/30/99 12/30/99 - Omnicef (cefdinir) Powder Oral Suspension Parke-Davis NDA 50-749/SE2-002 7/14/99 7/29/99 7/29/99 - - Omnicef Indication: 5-day dosing regimen (7 mg/kg BID) for the...
Dow Pharmaceutical Sciences - Show News Topical Formulations Skin Biology Analytical Stability Topicals Manufacturing Clinical Labeling Regulatory/Clinical Affairs Solano Clinical Research Company Mission Management Department Heads Tour -- Thursday, February 12 -- Back to News September 26, 2002 - - FOR IMMEDIATE RELEASE - - CONTACT: - Medicis, Scottsdale, Arizona - Libby Ivy, Executive Director, Investor Relations &...
URTI and SINUSITIS trevor langhan URTI and SINUSITIS trevor langhan URTI and SINUSITIS Trevor Langhan PGY-1 January 28, 2004 OBJECTIVES l Review common URTI’s presenting to the emergency department l Evidence supporting current URTI management Complications of URTI Sinusitis CASE l 8 year old boy brought in by mother with 3 day history of runny nose
author: trevor langhan
http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt 4Q2003 TYPE2ACTIVETEXT DMF # SUBMIT DATE HOLDER SUBJECT 131 01-Jan-40 CENTRAL SOYA SOYBEAN STEROL PRODUCTS 183 29-Feb-52 INTERNATIONAL SPECIALTY PRODUCTS POLYVINYL PYRROLIDONE-IODINE 10 191 24-Jan-56 MALLINCKRODT CHEMICAL INC PARZONE BITARTRATE (DIHYDROCODEINE BITARTRATE) 240 11-Jan-57 PHARMACIA & UPJOHN 19-NOR-ETHINYLTESTOSTERONE 281 21-Nov-57 UNIMED PHARMACEUTICALS INC 2 HYDROXY...
http://www.fda.gov/cdrh/pdf3/k033119.pdf Dillon Chuck Lake1 Pasco Laboratories 12750 West 42nd Avenue Wheat Ridge, Co 80033 3 03 90- 3 240 TRADE NAME OF DEVICE: Pasco MIC and MIC/ ID Panels COMMON NAME: Antimicrobial Susceptibility Test CLASSIFICATION NAME: Class I1 Antimicrobial Susceptibility Test Microbiology Panel #83 SUBSTANTIAL EQUIVALENCE: In review of previous 5 1O( k) notifications for the Pasco MIC and MIC/ ID...
http://www.fda.gov/cdrh/pdf3/k033119.pdf page 1
Methods - Cefuroxime , Doxylamine , Norfloxacin , Ofloxacin , Propofol -- - ANALYTE ---- LLOQ METHOD MATRIX -- A cebutolol 10.0 - ng/mL HPLC-UV Plasma -- -- diacetolol 10.0 - ng/mL -- - -- Acetaminophen 0.500 - mcg/mL HPLC-UV Plasma - Acyclovir 10.0 - ng/mL HPLC-Fluorescence Plasma - Albuterol 0.500 - ng/mL HPLC-Fluorescence Serum - Alprazolam 0.500 - ng/mL GC-ECD Serum - Amiodarone 5.00 -...
Reference Listed Drug Labeling Approved in June 2002 PEDIATRIC letter label multi-vitamins injection 18-920 SLR 024 --- TAXOTERE letter --- docetaxel injection 20-449 SLR 017 Jul 11 GLUCAGEN letter --- glucagon (rDNA origin) injection 20-918 SLR 003 ACTOS letter label pioglitazone tablet 21-073 SE8 010 --- AREDIA letter --- pamidronate disodium injection 20-036 SE8 026 Jul 12 HABITROL letter label nicotine transdermal system 20-076 SLR...
author: USERNAME
http://www.fda.gov/cdrh/pdf3/k032518.pdf Dillon Chuck Lake1 Pasco Laboratories 12750 West 42nd Avenue Wheat Ridge, Co 80033 3 03 9504 TRADE NAME OF DEVICE.: Pasco MIC and MIC/ ID Panels COMMON NAME: Antimicrobial Susceptibility Test CLASSIFICATION NAME: Class I1 Antimicrobial Susceptibility Test Microbiology Panel #83 SUBSTANTIAL EQUIVALENCE: In review of previous 5 1 O( k) notifications for the Pasco MIC and MIC/ ID panel:...
http://www.fda.gov/cdrh/pdf3/k032518.pdf page 1
1997 New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office
http://www.fda.gov/cdrh/pdf3/k032259.pdf Dillon Chuck Lake1 Pasco Laboratories 12750 West 42" d Avenue Wheat Ridge, Co 80033 3 03 TRADE NAME OF DEVICE: Pasco MIC and MICAD Panels COMMON NAME: Antimicrobial Susceptibility Test CLASSIFICATION NAME: Class I1 Antimicrobial Susceptibility Test Microbiology Panel #83 SUBSTANTIAL EQUIVALENCE: In review of previous 5 1 O( k) notifications for the Pasco MIC and MICAD panel: KO3 1205...
http://www.fda.gov/cdrh/pdf3/k032259.pdf page 1
RLD_LABELING_APPROVED_JUL_1999 Supp.No Firm Date VIDEX Didanosine chewable tablets 20-154 S-028 Bristol Myers Squibb 01-Jul-1999 VIDEX Didanosine for oral solution 20-155 S-020 Bristol Myers Squibb 01-Jul-1999 ZERIT Stavudine capsules 20-412 S-010 Bristol Myers Squibb 01-Jul-1999 ZERIT Stavudine oral solution 20-413 S-003 Bristol Myers Squibb 01-Jul-1999 CAVERJECT Alprostadil for injection 20-379 S-012 Pharmacia &...
FDA Drug Approvals List July 2002 45 Dosage Form: INJECTABLE Applicant: XCEL PHARMACEUTICALS Active Ingredient(s): DIHYDROERGOTAMINE MESYLATE OTC/RX Status: RX Application #: 020449 Labeling Supplement #: 019 To Original New Drug Application Approval Date: 30-JUL-02 Trade Name: TAXOTERE Dosage Form: INJECTABLE Applicant: AVENTIS PHARMACEUTICALS INC Active Ingredient(s): DOCETAXEL OTC/RX Status: RX Application #:...
